TrendFlares logo

Marinus Pharmaceuticals, Inc. (MRNS)

$1.60 5.96% $0.09 Healthcare

Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY, an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABAA receptors, a target for its anti-seizure, antidepressant, and anxiolytic potential. It is developing ganaxolone for treating genetic epilepsy disorders, such as PCDH19-related epilepsy, tuberous sclerosis complex, depressive disorders, and Lennox-Gestaut Syndrome. Marinus Pharmaceuticals, Inc. has license agreement with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc.; and collaboration agreement with Orion Corporation. The company was incorporated in 2003 and is headquartered in Radnor, Pennsylvania.

$88.13M

Dr. Scott N. Braunstein M.D.

113.00

Radnor, PA

Jul 31, 2014

-0.60

$-2.66

1.80

2.28

-493.14%

-0.59

-0.01

-1.87

2.82

2.15

-171.37%

-7,935.03%

Downtrend

Similar stocks (18)

Viking Therapeutics, Inc.

VKTX

$68.16 5.76%
Uptrend

Madrigal Pharmaceuticals, Inc.

MDGL

$242.25 3.90%
Downtrend

Edgewise Therapeutics, Inc.

EWTX

$29.50 54.69%
Uptrend

Akero Therapeutics, Inc.

AKRO

$28.00 3.86%
Uptrend

Mirum Pharmaceuticals, Inc.

MIRM

$39.35 3.83%
Neutral

Cullinan Oncology, Inc.

CGEM

$17.94 4.12%
Downtrend

89bio, Inc.

ETNB

$8.29 -0.24%
Downtrend

Terns Pharmaceuticals, Inc.

TERN

$10.04 -1.67%
Uptrend

Eliem Therapeutics, Inc.

ELYM

$8.28 3.76%
Uptrend

Inozyme Pharma, Inc.

INZY

$5.78 -0.52%
Uptrend

Cabaletta Bio, Inc.

CABA

$4.70 4.91%
Downtrend

Amylyx Pharmaceuticals, Inc.

AMLX

$2.88 0.00%
Downtrend

Acumen Pharmaceuticals, Inc.

ABOS

$2.58 5.74%
Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.71 0.63%
Downtrend

Ovid Therapeutics Inc.

OVID

$1.17 10.38%
Downtrend

Ikena Oncology, Inc.

IKNA

$1.71 3.01%
Neutral

PMV Pharmaceuticals, Inc.

PMVP

$1.52 0.66%
Downtrend

Immuneering Corporation

IMRX

$2.42 6.14%
Downtrend

ETF Exposure (15)

iShares Micro-Cap ETF

IWC

0.02031%

$126.54 2.19%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.008%

$24.66 1.07%
Uptrend

iShares Biotechnology ETF

IBB

0.00664%

$149.47 1.32%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.0022031429459344293%

$68.23 2.32%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

1.9e-4%

$125.25 1.78%
Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

0%

$49.96 1.07%
Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

0%

$49.95 1.07%
Uptrend

Vanguard Balanced Index Fund

VBINX

0%

$49.94 1.05%
Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

0%

$138.77 2.02%
Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

0%

$97.80 1.74%
Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

0%

$97.78 1.74%
Uptrend

Vanguard Total Stock Market Index Fund

VITSX

0%

$137.33 1.73%
Uptrend

Vanguard Total Stock Market Index Fund

VTI

0%

$282.05 1.69%
Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

0%

$137.30 1.73%
Uptrend

Vanguard Extended Market Index Fund

VXF

0%

$182.92 2.00%
Uptrend